Alzheimer’s drug study yields positive results in early stages of disease
Fox News
An experimental drug to treat Alzheimer’s, made by Eisai Co Ltd and Biogen, has yielded positive results. The drug has slowed functional decline by 27% compared to a placebo.
Speaking of the Eisai-Biogen drug results announced late on Tuesday night, Ronald Petersen, director of the Mayo Clinic Alzheimer's Disease Research Center in Rochester, Minnesota said: "It's not a huge effect, but it's a positive effect".
More Related News